INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
INO Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-10
Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-10 · Earnings Call
Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript
2025-11-10
Form 8-K - Current report
Key Events
2025-11-10 · Key Events
Form 8-K - Current report
2025-11-10
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-10 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
